Medtronic Plc 8-K Summary: Annual General Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of Medtronic Plc's 2019 Annual General Meeting of Shareholders held on December 6, 2019. The company is incorporated in Ireland and listed on the New York Stock Exchange under the symbol MDT.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for any financial indicators.
Material Changes
The filing details the outcome of six shareholder proposals. All proposals were approved by the shareholders. There are no material changes to financial operations or corporate structure reported in this document other than the ratification of governance authorities.
Guidance, Outlook, and Management Commentary
The filing contains no management commentary, financial guidance, outlook, risks, or contingencies. It strictly reports the voting tallies for the Annual General Meeting.
Key Facts for Investor Verification
- Quorum: 1,151,013,397 shares were present, representing a majority of the 1,340,697,277 outstanding shares.
- Director Elections: All 12 nominees were elected. Kendall J. Powell received the lowest support with 87.855% "For" votes, while Andrea J. Goldsmith and Elizabeth G. Nabel received over 99.6% support.
- Auditor Ratification: PricewaterhouseCoopers LLP was ratified as the independent auditor for fiscal year 2020 with 95.712% support.
- Executive Compensation: The "Say-on-Pay" proposal was approved with 94.726% support.
- Share Issuance and Buybacks: Shareholders approved the renewal of the Board's authority to issue shares, opt out of pre-emption rights, and authorize overseas market purchases of ordinary shares, all with over 98% support.